The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 14 results:
Author Title [ Type(Desc)] Year
Filters: Author is Tzilves, Dimitrios  [Clear All Filters]
Journal Article
Kountouras, J., Kapetanakis N., Zavos C., Polyzos S. A., Kouklakis G., Venizelos I., et al. (2014).  Active Helicobacter pylori infection is associated with colorectal mucosa-adenomatous polyp--early and advanced adenocarcinoma sequence.. Scand J Gastroenterol. 49(3), 381-2.
Zavos, C., Kountouras J., Katsinelos P., Polyzos S. A., Deretzi G., Zavos N., et al. (2011).  Association between Helicobacter pylori infection and fibromyalgia syndrome.. Clin Rheumatol. 30(2), 301-2.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Vardaka E., Kyrailidi F., Mouratidou M. C., et al. (2023).  Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome.. J Neurogastroenterol Motil. 29(3), 403-404.
Kountouras, J., Boziki M., Gavalas E., Zavos C., Grigoriadis N., Deretzi G., et al. (2009).  Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease.. J Neurol. 256(5), 758-67.
Kountouras, J., Zavos C., Deretzi G., Polyzos S. A., Katsinelos P., Anastasiadou K., et al. (2011).  Helicobacter pylori might be a potential therapeutic target in epilepsy.. Med Hypotheses. 76(5), 763.
Kountouras, J., Polyzos S. A., Zavos C., Deretzi G., Kountouras C., Vardaka E., et al. (2014).  Helicobacter pylori might contribute to nonalcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors.. Hepatology. 60(4), 1450-1.
Zavos, C., Kountouras J., Deretzi G., Tsona A., Polyzos S. A., Mantzoukis K., et al. (2012).  Hpn protein as a mediator between Helicobacter pylori infection and Alzheimer's disease in sub-populations worldwide.. Med Hypotheses. 78(2), 349-50.
Doulberis, M., Kountouras J., Polyzos S. A., Tzivras D., Vardaka E., Kountouras C., et al. (2018).  Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on gastroesophageal reflux disease- Barrett's esophagus- esophageal adenocarcinoma sequence.. Helicobacter. 23(6), e12534.
Kountouras, J., Boziki M., Gavalas E., Zavos C., Deretzi G., Grigoriadis N., et al. (2009).  Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease.. Int J Neurosci. 119(6), 765-77.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Tzilves D., Touloumtzi M., et al. (2023).  Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.. Aliment Pharmacol Ther. 57(10), 1186-1187.
Lazaraki, G., Akriviadis E., Pilpilidis I., Parisi I., Tzilves D., & Tarpangos A. (2011).  Low dose of bevacizumab is safe and effective in preventing bleeding episodes in hereditary hemorrhagic telangiectasia.. Am J Gastroenterol. 106(12), 2204-6.
Lazaraki, G., Katsinelos P., Nakos A., Chatzimavroudis G., Pilpilidis I., Paikos D., et al. (2011).  Malignant esophageal dysphagia palliation using insertion of a covered Ultraflex stent without fluoroscopy: a prospective observational study.. Surg Endosc. 25(2), 628-35.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Tzilves D., Lazaraki G., et al. (2023).  Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B.. J Viral Hepat.
Kountouras, J., Zavos C., Gavalas E., Deretzi G., Tsona A., Katsinelos P., et al. (2012).  A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein.. Cancer Immunol Immunother. 61(3), 445-6; discussion 447-51.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.